Ivan Wasserman Quoted in “The Fall of Chevron and the Potential Implications for Dietary Supplements”
Ivan Wasserman discussed the significant Chevron decision by the US Supreme Court and its industry impact with NutraIngredients-USA. Ivan stated that the majority recognized that Chevron deference was not being consistently applied by the courts, and it is not 100% clear what DSHEA-related FDA interpretations would have been entitled to deference and in what contexts (certainly mere statements would not have).
He went on to say that regardless, while some courts may still voluntarily give weight to FDA’s interpretations in some instances, they are generally no longer required to do so.
Read more here.
